arrow
U

Urška Kamenšek

institute of oncology ljubljana
H指数:21
被引数:1,170

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Tonon et al. 5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway. Cancers 2022, 14, 1630

更正:Tonon et al. 5-Azacytidine通过靶向miR-139-5p/ROCK2通路,在体外和体内下调肝细胞癌细胞的增殖和迁移。Cancers 2022, 14, 1630

Cancers
IF4.4
2026-03-120
OAAI
Nanoformulation of a Pin1 inhibitor potentiates the efficacy of liposomal doxorubicin in second-line therapy for ovarian cancer

一种Pin1抑制剂的纳米制剂能够增强脂质体多柔比星在卵巢癌二线治疗中的疗效

2025-11-130
PRE
Non-clinical evaluation of pmIL12 gene therapy for approval of the phase I clinical study
2024-09-272
OAAI
In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells

药物2c及其衍生物对卵巢癌细胞作用的体内外评价

2024-05-150
OAAI
Non-Clinical In Vitro Evaluation of Antibiotic Resistance Gene-Free Plasmids Encoding Human or Murine IL-12 Intended for First-in-Human Clinical Study

用于首次人体临床研究的编码人或鼠IL-12的无抗生素抗性基因质粒的非临床体外评估

2021-10-1912
OAAI
Strategies for Delivery of siRNAs to Ovarian Cancer Cells

将siRNAs递送至卵巢癌细胞的策略

2019-10-2220
OAAI